Peptonic Medical AB’s (publ) Annual Report 2015 published.
Stockholm 21st April, 2016. - Peptonic Medical (publ) - a company developing pharmaceuticals based on oxytocin - today announced that the 2015 Annual Report is available on the company’s website www.peptonicmedical.se and on the AktieTorget website www.aktietorget.se.
For more information, please contact;
Johan Inborr, CEO
Telephone: +46 708 853 893
About Peptonic Medical AB
Peptonic Medical AB (publ) is an innovative Swedish pharmaceutical company developing oxytocin based products e.g. for the treatment of menopausal symptoms, such as vaginal atrophy. Peptonic Medical’s mission is to develop safe and effective drugs based on the well-known beneficial properties of oxytocin.